JAIME WHITEHEAD: Open Payments
NPI 1053553024 · AUGUSTA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 26 payments from 4 companies in 2025. Trend: 2023 $15 · 2024 $167 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $291 |
| Averitas Pharma Inc. | 2 | $51 |
| Lilly USA, LLC | 2 | $32 |
| Incyte Corporation | 1 | $20 |
Products named: VRAYLAR, QUTENZA, Opzelura, MOUNJARO, ZEPBOUND.
Industry payments across AR — which companies pay providers there.
